SCHEMBL7642937

SCHEMBL7642937

CCCCOc1nsc(NC(=O)[C@@H](N)[C@@H](C)CC)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 1/20 0.43
SMN1; SMN2 Q16637 6/20 0.38
MAPT P10636 3/20 0.38
TP53 P04637 2/20 0.38
CIT O14578 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
SPHK1 Q9NYA1 4/20 0.36
LMNA P02545 4/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
POLB P06746 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
AAK1 Q2M2I8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7408066 0.88 XIAP (0.55) XIAPSMN1; SMN2MAPTTP53LMNA
SCHEMBL7644396 0.84 XIAP (0.43) XIAPSMN1; SMN2MAPTTP53CIT
SCHEMBL7642932 0.79 XIAP (0.34) XIAPSMN1; SMN2LMNANPC1RAB9A
SCHEMBL7637784 0.78 XIAP (0.43) XIAPSMN1; SMN2MAPTPIK3CDPIK3CA
SCHEMBL7643043 0.77 LNPEP (0.42) XIAPCIT
Hydrochloric Acid SCHEMBL7403586 0.77 RAB9A (0.41) XIAPSMN1; SMN2MAPTTP53LMNA
SCHEMBL7408062 0.76 XIAP (0.37) XIAPSMN1; SMN2LMNANPC1RAB9A
SCHEMBL7406241 0.73 L3MBTL1 (0.36) XIAPSMN1; SMN2MAPTLMNANPC1
Hydrochloric Acid SCHEMBL7403583 0.72 L3MBTL1 (0.36) XIAPSMN1; SMN2MAPTLMNANPC1
SCHEMBL8195939 0.71 GAA (0.40) SMN1; SMN2MAPTLMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468977-B1 COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS APOTEX INC. (CA) 2002-10-22 US disclosed